Nanoscope Kickstarts BLA Submission for Restorative RP Therapy, Adds to Advisory Board
BLA filed, big brains recruited—Nanoscope is charging ahead with its promising gene-agnostic therapy for retinitis pigmentosa. Nanoscope Therapeutics (Texas, USA)…
Biosimilar Interchangeability: FTC Backs FDA’s Simplification Push
On August 20, 2024, the Federal Trade Commission (FTC) released a comment expressing strong support for the U.S. Federal Drug…
latest posts